Open Angle Glaucoma Clinical Trial
Official title:
Validation of Retinal Oximetry in Glaucoma Patients: a Structural and Functional Correlation
Verified date | December 2010 |
Source | Universitaire Ziekenhuizen Leuven |
Contact | n/a |
Is FDA regulated | No |
Health authority | Belgium: Ethics Committee |
Study type | Observational |
Retinal ischemia is thought to play an important role in the pathogenesis of glaucoma. Up
until today, very little is known about the metabolic alterations in the retina of glaucoma
patients, since only techniques for surrogate measurements of metabolism (like blood flow
velocities and vessel diameter) were available. Oximetry has provided us with an important
tool to study metabolism in glaucoma, and to correlate these findings with the available
blood flow evaluation techniques. Preliminary results by the group of Prof Stefánsson (2011)
with the dual wavelength oximeter pointed out that deeper glaucomatous visual field defects
are associated with decreased arteriovenous differences in retinal oxygen saturation. These
data suggest that a change in oxygen metabolism occurs in glaucomatous retina. This reduced
oxygen metabolism may be related to tissue atrophy. However, this explanation is still
hypothetical, since the relation between these oximetry results and structural changes in
the optic nerve have not been studied yet.
1. What are the oximetry values in a normal population of within the same age group as the
glaucoma population? To answer this question, a normative database of the investigators
retinal oximetry device needs to be constructed for healthy controls.
2. Do glaucoma patients have different retinal oximetry values than these normal patients?
Are there any differences in retinal oxygenation between these glaucoma groups? To
answer these questions, oximetry measurements will be performed in patients with normal
tension glaucoma (NTG) and primary open angle glaucoma (POAG).
3. Is there an association between structural optic disc and retinal nerve fibre layer
changes, using Heidelberg Retinal Tomography (HRT), with alterations in retinal
vascular oxygen saturation in NTG and POAG patients?
4. Are blood flow measurements, using colour Doppler imaging (CDI), correlated with
alteration in retinal vascular oxygen in NTG and POAG patients?
Status | Completed |
Enrollment | 59 |
Est. completion date | December 2011 |
Est. primary completion date | December 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - individuals over 18 years old - willing to sign an informed consent and able to comply with the requirements of the study - having no other ocular diseases besides glaucoma Exclusion Criteria: - history of ocular trauma - intraocular surgery (except for cataract surgery) - eye disease (except glaucoma) - systemic diseases with ocular involvement like diabetes |
Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Belgium | Department of Ophthalmology, UZLeuven | Leuven |
Lead Sponsor | Collaborator |
---|---|
Universitaire Ziekenhuizen Leuven |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparison of oxygen saturation between glaucoma patients and healthy controls. | Retinal oximetry gives us oxygen saturation values who will be compared between glaucoma patients and healthy controls and will be correlated to visual field mean defect, structure parameters from the HRT and velocity measurements with the CDI. | patients will be followed during their hospital stay, an average. of 3 hours | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03284853 -
Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension
|
Phase 3 | |
Terminated |
NCT03611530 -
CoQun Study - (COQUN): a Study to Evaluate the Effects of CoQun in Patients Affected by Open-angle Glaucoma
|
N/A | |
Not yet recruiting |
NCT06441643 -
Next Generation Rocklatan
|
Phase 2 | |
Not yet recruiting |
NCT02868502 -
Different Glaucoma Treatments Effect on Intraocular Pressure Fluctuation With Postural Change in Eyes With Open-angle Glaucoma
|
N/A | |
Completed |
NCT02272569 -
STARflo European Safety and Efficacy Study
|
N/A | |
Completed |
NCT02628223 -
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
|
N/A | |
Completed |
NCT01936389 -
A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
|
Phase 2 | |
Completed |
NCT00941525 -
Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure
|
Phase 4 | |
Completed |
NCT00539526 -
Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues
|
Phase 4 | |
Completed |
NCT00121147 -
Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan
|
N/A | |
Active, not recruiting |
NCT05035394 -
Swedish Microinvasive Glaucoma Surgery Study (SMIGS)
|
N/A | |
Completed |
NCT03450629 -
Evaluation of Safety and Efficacy of PDP-716
|
Phase 3 | |
Active, not recruiting |
NCT06061718 -
Travoprost Intraocular Implant in Conjunction With Cataract Surgery
|
Phase 3 | |
Recruiting |
NCT05241938 -
PSLT Compared to Prostaglandin Analogue Eye Drops
|
N/A | |
Completed |
NCT01342406 -
Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics
|
||
Completed |
NCT02250612 -
SYL040012, Treatment for Open Angle Glaucoma
|
Phase 2 | |
Terminated |
NCT01983579 -
TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection
|
Phase 4 | |
Completed |
NCT01937299 -
Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®
|
Phase 4 | |
Completed |
NCT01937312 -
Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue
|
Phase 4 | |
Completed |
NCT01229982 -
A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
|
Phase 2 |